Sigma Planning Corp’s RAPT Therapeutics RAPT Stock Holding History

Sigma Planning Corp’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,000	Closed	-$644K	–	1382
2025 Q4	$644K	Buy	+19,000	New	+$590K	0.02%	709

Sigma Planning Corp's RAPT Position: Q1 2026 in Review

Sigma Planning Corp sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 19,000 shares — an estimated $644K sold.

Sigma Planning Corp first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $644K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Sigma Planning Corp reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Sigma Planning Corp sold 19,000 RAPT Therapeutics shares in Q1 2026, an estimated $644K.
Sigma Planning Corp first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Sigma Planning Corp's RAPT Therapeutics position peaked at $644K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.